'Patients first,' Pfizer CEO says of continuing to send supplies to Russia
Pfizer CEO Albert Bourla on Monday defended the company’s decision to continue supplying medicine to Russia, saying “patients first.”
The pharmaceutical company announced Monday that it would donate all profits from sales in Russia to Ukraine. Despite the hefty sanctions placed on Russia by countries around the world, Bourla said at the South by Southwest film festival in Austin that a humanitarian exemption to continue operations in Russia applies.
“Always with sanctions, medicines are excluded,” he said, citing other previous instances, including Iran. “We debated a lot what needs to be done, and we felt it’s so foundational in our principles that patients should come first that we cannot stop the flow of our medicines to Russia.”
Bourla emphasized that medicine is not comparable to goods such as the latest smartphone, saying that treatments for conditions such as lung and metastatic breast cancer “can’t stop.”
However, Pfizer is not "continuing business as usual" in Russia, Bourla said.
“Though we will maintain the flow of the medicines, we will not make money out of it -- all the profits of the Russian subsidiary going forward effective immediately will be donated to causes to alleviate the pain that the invasion is causing to Ukrainians.”
-ABC News' Sasha Pezenik